Prostatic Neoplasms: all 6,484 studies
Page 39 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate CancerCompletedNCT03793543Phase 1
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCTerminatedNCT03792841Phase 1
- Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARPCompletedNCT03790995
- Personalized Mini-PDX for Metastatic CRPCStatus unknownNCT03786848Not applicable
- A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsCompletedNCT03784677Phase 1
- The Biopsychosocial Burden of Prostate BiopsyCompletedNCT03783741
- Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate CancerStatus unknownNCT03780075Phase 1
- A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug SwitchCompletedNCT03778047Phase 1
- A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its PharmacokineticsCompletedNCT03776968Phase 1
- PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)CompletedNCT03776045Not applicable
- A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients.CompletedNCT03774056Phase 1
- Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate CancerActive, not recruitingNCT03772834Phase 2/3
- Early Prostate Cancer: Predicting Treatment ResponseStatus unknownNCT03770351
- PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate CancerCompletedNCT03768349Early Phase 1
- A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyActive, not recruitingNCT03767244Phase 3
- Docetaxel Versus Cabazitaxel Post Abiraterone or EnzalutamideTerminatedNCT03764540Phase 2
- Cannabis Oil and Radiation Therapy for the Management of PainTerminatedNCT03763851Phase 2
- Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment AlgorithmsActive, not recruitingNCT03763253Phase 2
- Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate CancerCompletedNCT03761225Phase 3
- Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation TherapyCompletedNCT03761160Not applicable
- Expanded Access to NanoPacNo longer availableNCT03756311
- A Study of the Value of Hybrid PET/MR and PET/CT in Prostate CancerStatus unknownNCT03756077
- Initiative to Minimize Disparities in Postoperative Prostate Cancer CareTerminatedNCT03755492
- Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.Active, not recruitingNCT03753334Phase 2
- Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate CancerStatus unknownNCT03753243Phase 2
- To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerTerminatedNCT03752099Phase 1/2
- Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03751436Phase 1
- Evaluation of a MRI-based Prostate Cancer Screening ProgramCompletedNCT03749993Not applicable
- Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate CancerWithdrawnNCT03748719Not applicable
- Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate CancerCompletedNCT03744494Not applicable
- A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPCTerminatedNCT03741712Phase 1/2
- The Effects of Two Different Ventilation Strategies on Lung Ventilation: An Ultrasonographic Evaluation.Status unknownNCT03740854Not applicable
- Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate CancerTerminatedNCT03740191Not applicable
- Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer PatientsTerminatedNCT03740035
- Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate CancerCompletedNCT03737370Phase 1
- Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate CancerCompletedNCT03734757Not applicable
- Testosterone Therapy in Castration Resistant Prostate CancerCompletedNCT03734653Early Phase 1
- ClariCore System Used in Transperineal Prostate BiopsySuspendedNCT03734575Not applicable
- Predicting Prostate Biopsy Results With Biomarkers and mpMRI.CompletedNCT03730324Not applicable
- Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03724747Phase 1
- Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate AdenocarcinomaTerminatedNCT03718338
- PSMA-PET Registry for Recurrent Prostate CancerCompletedNCT03718260Not applicable
- Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate CancerWithdrawnNCT03709550Phase 1/2
- Evaluation of Gut Microbiome in Patients With Prostate CancerStatus unknownNCT03709485Not applicable
- Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyCompletedNCT03707574
- Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)Active, not recruitingNCT03703778
- Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by EnzalutamideActive, not recruitingNCT03700099Phase 2
- Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate CancerActive, not recruitingNCT03697148Not applicable
- Selective Treatment According to Molecular Subtype of Prostate CancerStatus unknownNCT03696186Phase 2
- Prostasomes as Diagnostic Tool for Prostate Cancer DetectionSuspendedNCT03694483
- Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate CancerCompletedNCT03693703Not applicable
- Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate CancerStatus unknownNCT03692663Early Phase 1
- Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital BehaviorCompletedNCT03692585
- US-CT Fusion for Post Implant DosimetryCompletedNCT03692104
- Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate CancerStatus unknownNCT03692000
- External Validation of Prostate MRI QCAD/LyonStatus unknownNCT03687918
- Laparoscopic vs Robotic-Assisted Radical ProstatectomyCompletedNCT03682146Not applicable
- Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate CancerCompletedNCT03679819
- Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active SurveillanceCompletedNCT03679260Phase 2
- Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate CancerStatus unknownNCT03677414
- Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate CancerCompletedNCT03677076
- The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.CompletedNCT03675529Not applicable
- Safety and Security Evaluation of Patients Submitted to Minimally Invasive Radical ProstatectomyCompletedNCT03674996Not applicable
- Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate CancerCompletedNCT03674814Phase 1
- Focal Prostate Ablation Versus Radical ProstatectomyCompletedNCT03668652Not applicable
- Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate CancerCompletedNCT03665922Not applicable
- Comparison of a Novel Leuprolide With Market LeuprolideStatus unknownNCT03662958Not applicable
- Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study)Status unknownNCT03658525Not applicable
- Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility TrialCompletedNCT03658486Not applicable
- PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)CompletedNCT03658447Phase 1/2
- Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate CancerStatus unknownNCT03658434Not applicable
- Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality ModelsCompletedNCT03656822
- Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility TrialCompletedNCT03655886Phase 2
- High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower LimbsCompletedNCT03653819Not applicable
- Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and PartnersTerminatedNCT03652298Phase 2
- Clinical Application of 68Ga-PSMA PET in Prostate CancerStatus unknownNCT03650946
- Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. TransperinealCompletedNCT03650153Not applicable
- Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)CompletedNCT03643107Phase 2
- STHLM3 - Prostate Cancer Diagnostic TrialCompletedNCT03639649Not applicable
- PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted BiopsyCompletedNCT03635866Not applicable
- Evaluation of An Online Intervention In Improving General Practitioners' Practice In Prostate Cancer ScreeningStatus unknownNCT03633214Not applicable
- Dynamic Focusing Evaluation for Prostate Cancer TreatmentStatus unknownNCT03632980Not applicable
- Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.Status unknownNCT03630926
- Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer PatientsActive, not recruitingNCT03630666Not applicable
- Dose-Escalated Proton Radiation Therapy for High-Risk Prostate CancerActive, not recruitingNCT03624660Phase 2
- Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate CancerStatus unknownNCT03623425Phase 3
- A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or DeathCompletedNCT03619980
- Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to TherapyTerminatedNCT03619655Phase 1
- Trial of eRapa in Prostate Cancer PatientsCompletedNCT03618355Phase 1
- Plant-based Diets and Risk of Cancer in the Adventist Health Study-2Active, not recruitingNCT03615599
- Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate CancerCompletedNCT03615131
- Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE StrategiesActive, not recruitingNCT03611686
- PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real LifeStatus unknownNCT03609736
- CamPROBE: Developing a Safer and Simple Device for Local Anaesthetic Transperineal Prostate BiopsiesCompletedNCT03609528Not applicable
- Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-prostatectomy AnalgesiaTerminatedNCT03606889Not applicable
- 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer ImagingCompletedNCT03606837Phase 2
- 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic RisksCompletedNCT03604757Phase 2
- SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution ExperienceCompletedNCT03604211
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/2
- Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer PatientsStatus unknownNCT03601143